Skip to main content
SpringerLink
Log in

UK NICE issues guidance on early breast cancer therapy

  • Guideline
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. National Institute for Health and Clinical Excellence.Hormonal therapies for the adjuvant treatment of early oestrogen-receptor-positive breast cancer. Technology Appraisal Guidance: 1-37, No. 112, Nov 2006. Available from: URL: http://www.nice.org.uk

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

UK NICE issues guidance on early breast cancer therapy. Pharmacoecon. Outcomes News 518, 3 (2006). https://doi.org/10.2165/00151234-200605180-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200605180-00004

Keywords

Search

Navigation